#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary ataxia Basal cell naevus syndrome Glomerulonephritis acute Mucopolysaccharidosis II Cardiac arrest Mitochondrial DNA depletion Follicular lymphoma stage II Chronic graft versus host disease in liver Arrhythmogenic right ventricular dysplasia Adenomatous polyposis coli Blastic plasmacytoid dendritic cell neoplasia Cushing's syndrome Graft versus host disease Hereditary angioedema with C1 esterase inhibitor deficiency Inclusion body myositis More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder – Diagnostics Methylmalonic acidaemia – Life with Disease Haemophilia A with anti factor VIII – Trials in Disease Hereditary motor and sensory neuropathy – Treatment Pemphigus – Basic Information Haemophilia A without inhibitors – Treatment Burkitt’s lymphoma – Trials in Disease Mucopolysaccharidosis – Treatment Friedreich’s ataxia – Life with Disease Ewing’s sarcoma metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dornase Alfa Sodium Valproate Gen1055 Pimozide Calcium Chloride Dihydrate Rbl016.2 AZD4512 Secukinumab Cetirizine RIMIDUCID R-Azasetron Besilate Flortaucipir (18F) Acp-017 Sodium Fluoride (18F) BRENSOCATIB Gad20-209-Fsp-A1 Tamoxifen Citrate Cilastatin Tulisokibart Lauromacrogol 400 More therapies…

    Learn about Your Condition

    Dermatitis Myocarditis Diabetes insipidus Dizziness T-cell lymphoma Bone sarcoma Vaginal infection Angiosarcoma metastatic Normal pressure hydrocephalus Orthostatic hypotension Post procedural infection Ewing's sarcoma metastatic Hyperparathyroidism primary Renal cancer recurrent Papilloma viral infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Niraparib with Immunotherapy for Patients with SLFN11-Positive Extensive-Stage Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Small cell lung cancer
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    • Atezolizumab
    • Durvalumab
    France Germany Italy Romania Spain

  • Study on the Effect of Nivolumab and Melphalan in Patients with In-Transit Melanoma Metastases

    Recruiting

    2 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Nivolumab
    • Sodium Chloride
    The Netherlands Sweden

  • Study of Lower Blood Pressure Targets Using Noradrenaline in Patients with Heart Attack-Related Cardiogenic Shock

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiogenic shock
    • Acute myocardial infarction
    Investigated Drugs:
    • Noradrenaline Tartrate
    Belgium Czechia Denmark Germany Greece The Netherlands +3

  • Study on the Effects of Removing Dexamethasone from Premedication in Paclitaxel Treatment for Patients with Solid Tumors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Dexamethasone Sodium Phosphate
    • Dexamethasone
    The Netherlands

  • Study on the Safety and Effects of Fosigotifator in Adults and Children with Vanishing White Matter Disease

    Recruiting

    1 1 1
    Investigated Diseases:
    • White matter lesion
    Investigated Drugs:
    • Sodium ({(2S)-1,4-Bis[2-(4-Chloro-3-Fluorophenoxy)Acetamido]Bicyclo[2.2.2]Octan-2-Yl}Oxy)Methyl Hydrogen Phosphate-2-Amino-2-(Hydroxymethyl)Propane-1,3-Diol (1/1/1)
    The Netherlands

  • Study Comparing Lidocaine Gel and Tetracaine/Oxybuprocaine Eye Drops for Glaucoma Patients Undergoing Outpatient Needling Procedures

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glaucoma
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Oxybuprocaine Hydrochloride
    • Tetracaine Hydrochloride
    Spain
Previous Page
1 … 438 439 440 441 442 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!